Dermatology · Wilmington, NC
NPI
1134187594
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1099 Medical Center Dr Ste 201
Wilmington, NC, 28401
Phone (910) 251-9944
Groups this clinician bills Medicare through
Medicare paid, 2024
$268K
7,857 services
Medicare patients, 2024
1,248
Average age 75
Drug cost, 2024
$1.1M
3,303 prescriptions
Company payments, 2025
$4,220
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jonathan S Crane was code 17003 (destruction skin lesion), 3,979 times for 521 patients. In total Jonathan S Crane billed 7,857 services in 58 codes, and Medicare paid $268K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 3,979 | 521 | $4.52 | $18K |
| 99213 Office E&M - Established | Office | 1,049 | 750 | $59.30 | $62K |
| 17000 Destruction Skin Lesion | Office | 849 | 628 | $38.07 | $32K |
| 11102 Skin Biopsy | Office | 491 | 387 | $66.18 | $32K |
| 17004 Destruction Skin Lesion | Office | 292 | 190 | $111.38 | $33K |
| 99212 Office E&M - Established | Office | 292 | 265 | $37.01 | $11K |
| 11103 Skin Biopsy | Office | 253 | 145 | $34.51 | $8,731 |
| 12032 Wound Repair - All Levels | Office | 112 | 106 | $219.23 | $25K |
| 17261 Destruction Skin Lesion | Office | 48 | 41 | $97.04 | $4,658 |
| 11603 Skin Lesion Excision | Office | 40 | 39 | $111.19 | $4,447 |
| 11602 Skin Lesion Excision | Office | 38 | 38 | $95.99 | $3,648 |
| 11402 Skin Lesion Excision | Office | 36 | 33 | $70.43 | $2,535 |
| 17110 Destruction Skin Lesion | Office | 36 | 32 | $78.84 | $2,838 |
| 17262 Destruction Skin Lesion | Office | 32 | 28 | $117.63 | $3,764 |
| 69100 Other Organ Systems | Office | 19 | 17 | $55.95 | $1,063 |
By year: 2022 $316K for 9,779 services; 2023 $265K for 8,256 services; 2024 $268K for 7,857 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jonathan S Crane prescribed most often to Medicare patients was Ciclopirox (Ciclopirox Olamine), with 593 prescriptions and refills. In total Jonathan S Crane wrote 3,303 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ciclopirox Ciclopirox Olamine | 593 | 642 | 289 | $10K |
| Ketoconazole Generic | 580 | 638 | 221 | $7,577 |
| Mupirocin Generic | 289 | 290 | 217 | $2,132 |
| Doxycycline Monohydrate Generic | 222 | 330 | 170 | $3,751 |
| Fluorouracil Generic | 207 | 221 | 168 | $15K |
| Tacrolimus Generic | 188 | 202 | 108 | $15K |
| Ciclopirox Generic | 165 | 176 | 75 | $4,207 |
| Metronidazole Generic | 120 | 130 | 70 | $17K |
| Doxycycline Hyclate Generic | 96 | 123 | 72 | $656 |
| Triamcinolone Acetonide Generic | 72 | 72 | 64 | $488 |
| Clobetasol Propionate Generic | 67 | 68 | 54 | $1,300 |
| Otezla Apremilast | 59 | 59 | Under 11 | $283K |
| Valacyclovir Valacyclovir Hcl | 58 | 99 | 32 | $2,028 |
| Calcipotriene Generic | 55 | 58 | 30 | $7,719 |
| Clindamycin Phosphate Generic | 54 | 61 | 30 | $1,355 |
Brand drugs: 307 claims; generic drugs: 2,996 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jonathan S Crane $4,220 ($4,220 in general payments such as food, travel and fees) from 21 companies. The largest payer was Abbvie Inc. with $786.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 22 | $786 |
| UCB, Inc. UCB.BR | 10 | $581 |
| Janssen Biotech, Inc. JNJ | 12 | $504 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 6 | $325 |
| Genzyme Corporation SNY | 12 | $279 |
| LEO Pharma Inc. | 3 | $247 |
| Organon LLC OGN | 9 | $234 |
| Pfizer Inc. PFE | 3 | $230 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $190 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $185 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.